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To the best of our knowledge, a total of 234 cases of PEComas NOS have been reported in English published reports. Of those, 47 were uterine PEComas cases, which included 31 tumors of benign behavior and 16 tumors of locally aggressive behavior with distant metastasis to liver, lungs, intestines, bone, and lymph nodes. Here, we report a very rare malignant uterine PEComa with lung metastasis in a 49yearold unmarried woman, de spite adjuvant chemotherapy after initial surgery.
CASE REPORT
A 49yearold unmarried woman visited a gynecologist com plaining of her abnormal uterine bleeding, which had lasted for 1 week. Her past medical history was unremarkable. Upon vag inal examination, the uterus was slightly enlarged and there was a moderate tenderness in the lower abdomen. Ultrasonography showed a 9.5 cm×8.0 cm×7.5 cmsized tumor with high vas cularity, arising from the anterior wall of the uterine corpus. Vi tal signs were within normal range. The initial laboratory find ings were normal, except for a low hematocrit level of 28%. The chest Xray showed no active lung lesions (Fig. 1A) . Under the diagnosis of uterine leiomyoma, she was taken to the operative room the following day. During the explorative laparotomy, a large, fungating, vascular mass arising from the anterior wall of the uterine corpus was noted. Myomectomy was performed be cause of her desire to preserve the uterus. The specimen was sent to a pathologist for frozen section. The pathologist conformed that the mass was highly suspicious for malignancy with high mitotic figures and marked nuclear anaplasia. Consequently, a total abdominal hysterectomy and bilateral salpingooophorec tomy was perform ed. On gross examination, the tumor was an ovoid firm myomatous nodule (8.5×8.0×6.5 cm). On section, the cut surface of the mass showed yellow white fishfleshy ap pearance with multifocal necrosis (Fig. 2A) . Microscopic review revealed that the tumor cells were predominantly composed of epithelioid cells with eosinophilic cytoplasm. Also, an extensive area of trabecular arrangement, marked nuclear anaplasia, ne crosis and vascular invasion was noted. Twenty mitotic figures per 10 highpower fields were observed (Fig. 2B) . In immuno histochemical staining, the neoplastic cells were strongly posi tive for human melanoma black 45 (HMB45) (Fig. 2C ) and smooth muscle actin (SMA) (Fig. 2D ), whereas they were nega tive for p53, desmin, creatine kinase, ckit, and CD10. In com bination of these pathological features and the myelomelano cytic phenotype of the tumor, the final diagnosis was uterine PEComa. Considering the large size of the tumor and the pres ence of multiple high risk features as proposed by Folpe et al., 2 a malignant or highrisk PEComa was suspected (Table 1) . After surgery, the patient underwent three sessions of adjuvant che motherapy (doxorubicin hydro chloride+haloxan) and was fol lowed up regularly. Seven months later, the patient was taken to an emergency room with general weakness, high fever (38.6°C) and dyspnea. The chest Xray and computed tomo graphy (CT) findings showed multiple round nodules with variable sizes in both lungs which were suspected as metastasis (Fig. 1B, C) . Af ter admission, the patient started chemotherapy again with the same drugs as previously used, but expired during the treatment due to pneumonia. The patient's family gave an informed con sent to the publication.
DISCUSSION
The perivascular epithelioid cell was first addressed by Bonet ti et al. in 1992, 3 according to its morphological and immuno histochemical features. Subsequently, they further pro posed that the diseases with the same phenotype, including angiomyolipo ma (AML), clear cell "sugar" tumor (CCST) of the lung, and lymphangioleiomyomatosis (LAM), be a panel of entity. Then, in 1996, PEComa was proposed by Zamboni et al. 4 The PECo ma family of tumors comprised of AML, CCST of the lung, LAM, and less wellcharacterized PEComas of other anatomic origins, for which the term PEComaNOS has been proposed. PEComaNOS is a collection of rare tumors defined as a mesen chymal tumor composed of perivascular epithelioid cells with distinctive morphological and immunohistochemical features. 5 PEComaNOS has now been reported in almost every body site, including gynecological, genitourinary, gastrointestinal, extrem ities, skin, heart, breast, oral cavity, orbit, and skull base. Spe cifically, uterus is the most prevalent site of PEComaNOS. 5 Most of the patients with uterine PEComas show abnormal uterine bleeding or lower abdominal pain with a palpable mass, which is similar to the symptoms and signs of other uterine tu mors. Thus, uterine PEComas can often be misdiagnosed as uterine leiomyomas before surgery. Most clinical courses of uter ine PEComa are benign, and malignant tumors are rare. Further more, distant metastasis to the lung in malignant PEComa of the uterus is extremely rare. Distant metastatic diseases of uter ine PEComas are only 6.8% (16/234) of all cases. The most com mon location of distant metastasis was lung (7 cases), which was followed by bone (5 cases), ovary, liver, adrenal gland and peri toneal wall. The risk of metastasis depends on the size of the primary mass and the presence of multiple high risk features. 2 CT findings are pathognomonic, showing multiple round nod ules of variable sizes distributed throughout the lungs, includ ing the costophrenic angles, with normal intervening lung pa renchyma. 6 Since PEComa has no distinctive symptoms and signs, the diagnosis should depend on pathological examina tions. PEComas are usually composed of epithelioid, but occa sionally spindled cells, with clear to granular eosinophilic cyto plasm and focal perivascular accentuation. 7 In our case, the tu mor cells were predominantly composed of epithelioid cells with eosinophilic cytoplasm. In addition, mitotic figures and necrosis can be observed. Thinwalled blood vessels are readily visible around the smooth muscle with unclear boun daries. Also in immunohistochemical staining, these tumors are positive for markers of both melanocytic (HMB45, MelanA, and tyrosi nase) and myoid (desmin, SMA, musclespecific actin, caldes mon, and calponin) differentiation. 8 Schoolmeester et al. 9 re ported that HMB45 in PEComas is the most sensitive (16/16 positive, 100%) marker, followed by MiTF (11/12 positive, 92%) and MelanA (14/16 positive, 88%); all three muscle mar kers were expressed by most tumors in that study. Desmin was positive in 15 of 15 cases (100%), SMA was positive in 14 of 15 cases (93%), and hcaldesmon was positive in 11 of 12 cases (92%). 9 Fadare reported that PEComas are immunoreactive for melanocytic markers and most frequently, HMB45. Further more, 49% (19/35 cases) and 73% (24/33 cases) of PEC omas are immunohistochemically positive for desmin and SMA, re spectively. 10 In our case, the tumor showed strong and diffuse positivity for both HMB45 and SMA in immunohistochemi cal staining, whereas it was negative for p53, desmin, and CD10.
The uterine PEComas should be differentiated from other uterine tumors, such as epithelioid leiomyoma, leiomyosarcoma and endometrial stromal sarcoma (ESS). 6 These tumors and PEC oma can share, at least in part, some histological appearances and immunoprofiles, including expression of melanocytic and smooth muscle markers. 7 Epithelioid leiomyoma shows focal or no immunoreactivity for HMB45, with positivity for SMA and desmin. HMB45 positivity, often focal, has been found in 31% to 36% of conventional leiomyosarcomas, but leiomyosar coma without clear cell areas has been found to be negative for HMB45. 9 Immunoreactivity for HMB45 has been found only in clear cell areas. ESS shows negative staining for HMB45, SMA, and desmin. 10 Therefore, the distinction between PECo mas and epithelioid smooth muscle tumors should be largely a morphologic exercise: the latter lacks the vascular network of the former and will typically show at least focal conventional areas. 9, 10 Although PEComas have a wide spectrum of biologi cal behavior, convincing criteria for malignancy have not yet been established. As mentioned earlier, a proposed classification of PEComas adapted from Folpe et al. 2 has been widely used up to now. Our case, a large tumor with marked nuclear anaplasia, necrosis, high mitotic figures, and vascular invasion of the tu mor cells, conforms to the malignant or highrisk PEComa ac cording to the proposed classification. Optimal treatment for PEComas has not been well established at this time. Currently, surgery is the mainstay of treatment. Although radiotherapy, chemotherapy or immunotherapy is being implemented as an adjuvant treatment for malignant PEComa after surgery, the actual effect has not been well demonstrated. Because malig nant PEC oma portends a poor prognosis, treatment strategies incorporating surgery, radiotherapy and chemotherapy should be considered.
